"Executive Summary: The Global Smith-Magenis Syndrome Drug Market size was valued at USD 120 million in 2024 and is expected to reach USD 192.71 million by 2032, at a CAGR of 6.1% during the forecast period  The global Smith-Magenis Syndrome Drug Market is witnessing accelerated growth, fueled by increasing demand, evolving consumer preferences, and...